|
Issue |
Title |
|
No 3 (2022) |
Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group |
Abstract
PDF (Rus)
|
S. B. Fitilev, Yu. F. Glukhov, S. V. Lukyanov, V. I. Kazey, I. B. Bondareva, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev |
|
No 3 (2022) |
Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats |
Abstract
PDF (Rus)
|
S. S. Boyko, K. N. Koliasnikova, V. P. Zherdev |
|
No 2 (2022) |
Disribution kinetics of cardioprotector ALM-802 in rat organs and tissues |
Abstract
PDF (Rus)
|
O. Yu. Kravtsova, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, V. P. Zherdev |
|
No 2 (2021) |
Pharmacokinetics and neurotropic effects of cyclo-L-prolylglycine and its modified analogues |
Abstract
PDF (Rus)
|
S. S. Boyko, V. P. Zherdev, K. N. Koliasnikova |
|
No 1 (2013) |
Examine the pharmacokinetics of three formulations of the drug for regenerative gene therapy damage the surface of human tissues of various etiologies |
Abstract
PDF (Rus)
|
I. V. Duhovlinov, R. I. Al-Shekhadat, A. I. Orlov |
|
No 1 (2013) |
Excretion connection VMA-99-82 — a novel adenine having antiviral activity |
Abstract
PDF (Rus)
|
L. A. Smirnova, E. A. Suchkov, A. F. Ryabukha, K. A. Kuznetsov, A. A. Ozerov, A. V. Karavaev |
|
No 2 (2013) |
Experimental study of the pharmacokinetics of rifabutin in liposomal form |
Abstract
PDF (Rus)
|
M. V. Carlin, V. M. Cosman, O. N. Pozharitskaya, A. N. Shikov, M. N. Makarova, V. G. Makarov, V. Y. Balabanyan |
|
No 1 (2014) |
Role of 3-oximetabolite phenazepam and levan in realize their neurotropic efficacy |
Abstract
PDF (Rus)
|
T. A. Voronina, V. B. Larionov, N. Y. Golovenko, L. N. Nerobkova, I. O. Gaidukov |
|
No 1 (2014) |
Excretion of the drug glutaron - a new derivative of glutamic acid |
Abstract
PDF (Rus)
|
L. A. Smirnova, E. A. Suchkov, A. F. Ryabukha, K. A. Kuznetsov, I. N. Tyurenkov, V. N. Perfilova |
|
No 1 (2014) |
Coordination compounds cobalt bis(citrate)stannate - are results of searching new antiinfluenza drugs |
Abstract
PDF (Rus)
|
M. V. Matyushkina, V. V. Godovan, I. I. Seyfullina, T. L. Grydina |
|
No 1 (2014) |
Drug-drug interactions in the new antiepileptic drugs: focus to perampanel and zonisamide |
Abstract
PDF (Rus)
|
Y. B. Belousov |
|
No 1 (2015) |
Preclinical study the pharmacokinetics new anxiolytic drug of dipeptide structure GB-115 |
Abstract
PDF (Rus)
|
V. P. Zherdev, S. S. Boyko, E. V. Blynskaya, K. G. Turchinskaya, T. A. Gudasheva, E. V. Ivannikova |
|
No 2 (2016) |
N-acetylcysteine: pharmacokinetic parameters and the effect on the concentration of endogenous aminothiols |
Abstract
PDF (Rus)
|
A. A. Dutov, D. A. Nikitin, J. L. Lukianova, N. A. Shemyakina, A. V. Ermolina, M. N. Mishchenko |
|
No 3 (2016) |
Assessment of pharmacokinetics-pharmacodynamics relationship of tropoxine in rats |
Abstract
PDF (Rus)
|
V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, A. A. Novitskyi, T. S. Ganshina, A. A. Gorbunov, R. S. Mirzoyan |
|
No 4 (2016) |
A comparative study of pharmacokinetics of coated tablets of mycophenolic acid |
Abstract
PDF (Rus)
|
A. L. Khokhlov, I. I. Yaichkov, A. M. Shitova, L. N. Shitov, Yu. A. Dzhurko, A. E. Miroshnikov |
|
No 2 (2017) |
Pharmacokinetic comparative study of tropoxine metabolite in miscellaneous animal species and humans |
Abstract
PDF (Rus)
|
V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, R. V. Shevchenko, O. G. Grybakina, T. S. Ganshina |
|
No 3 (2017) |
Effect of triftazin (trifluoperazine) on the symptoms of autism spectrum disorders in rats with fetal valproatate syndrome |
Abstract
PDF (Rus)
|
I. G. Kapitsa, E. A. Ivanova, T. A. Voronina, G. V. Protsun |
|
1 - 17 of 17 Items |
|